Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 7, 2016, Pages

  Elsner, Bernhard ^a,b   Kugler, Joachim ^a   Pohl, Marcus ^c   Mehrholz, Jan ^d  

^a UNIVERSITY OF DRESDEN MEDICAL SCHOOL   (Germany)

^b Department of Physiotherapy   (Germany)

^c Helios Klinik Schloss Pulsnitz   (Germany)

^d Klinik Bavaria in Kreischa GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CLINICAL EFFECTIVENESS; DAILY LIFE ACTIVITY; DISABILITY; DYSKINESIA; HUMAN; IDIOPATHIC DISEASE; MOVEMENT THERAPY; NERVE CELL EXCITABILITY; NEUROMODULATION; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; ADULT; DYSKINESIAS; META ANALYSIS; PATHOPHYSIOLOGY;

ADULT; DYSKINESIAS; HUMANS; PARKINSON DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSCRANIAL DIRECT CURRENT STIMULATION;

EID: 84978371832     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010916.pub2     Document Type: Review

References (87)

1. Benninger D, Lomarev M, Lopez G, Wassermann E, Considine E, Hallett M. Transcranial direct current stimulation for the treatment of Parkinson's disease: a randomized, double-blind, sham-controlled study. Neurology 2009; Vol. 72, issue 11:A413. [0028-3878]
2. Benninger D, Lomarev M, Lopez G, Wassermann E, Li X, Considine E, et al. Transcranial direct current stimulation for the treatment of Parkinson's disease: A randomized, double-blind, sham-controlled study. Movement Disorders 2009; Vol. 24:S256. [0885-3185]
3. Benninger DH, Lomarev M, Lopez G, Wassermann EM, Li X, Considine E, et al. Transcranial direct current stimulation for the treatment of Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2010; Vol. 81, issue 10:1105-11. [0022-3050]
4. NCT00082342 . Transcranial direct current stimulation to treat symptoms of Parkinson's disease. www.ClinicalTrials.gov/show/NCT00082342 (accessed 25 February 2014).
5. Kaski D, Dominguez R, Allum J, Islam A, Bronstein A. Combining physical training with transcranial direct current stimulation to improve gait in Parkinson's disease: a pilot randomized controlled study. Clinical Rehabilitation 2014 May 21 [Epub ahead of print]. [1477-0873: (Electronic); ]
6. Kaski D, Dominguez R, Allum J, Islam A, Bronstein A. Combining physical training with transcranial direct current stimulation to improve gait in Parkinson's disease: a pilot randomized controlled study. Clinical Rehabilitation 2014 May 21 [Epub ahead of print].
7. NCT01877148 . Effects of transcranial direct current stimulation associated with physical therapy on motor rehabilitation in Parkinson's disease patients. www.ClinicalTrials.gov/show/NCT01877148 (accessed 25 February 2014).
8. Valentino F, Cosentino G, Brighina F, Pozzi NG, Sandrini G, Fierro B, et al. Transcranial direct current stimulation for treatment of freezing of gait: A cross-over study. Movement Disorders 2014 Apr 30 [Epub ahead of print]. [1531-8257: (Electronic); ]
9. Verheyden G, Purdey J, Burnett M, Cole J, Ashburn A. Immediate effect of transcranial direct current stimulation on postural stability and functional mobility in Parkinson's disease. Movement Disorders 2013;28(14):2040-1.
10. Baijens LW, Speyer R, Passos VL, Pilz W, Roodenburg N, Clavé P. The effect of surface electrical stimulation on swallowing in dysphagic Parkinson patients. Dysphagia 2012;27(4):528-37.
11. Biundo R, Weis L, Fiorenzato E, Gentile G, Giglio M, Schifano R, et al. Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training. Brain Stimulation 2015; Vol. 8, issue 6:1223-5. [1935-861X]
12. Boggio PS, Ferrucci R, Rigonatti SP, Covre P, Nitsche M, Pascual-Leone A, et al. Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease. Journal of the Neurological Sciences 2006;249(1):31-8. [0022-510X]
13. Fregni F, Boggio PS, Santos MC, Lima M, Vieira AL, Rigonatti SP, et al. Noninvasive cortical stimulation with transcranial direct current stimulation in Parkinson's disease. Movement Disorders 2006;21(10):1693-702. [0885-3185]
14. Eggers C, Gruner U, Ameli M, Sarfeld AS, Nowak DA. 1Hz rTMS preconditioned by tDCS over the primary motor cortex in Parkinson's disease: Absence of effect on arm lift and hand grip force control. Motor Control 2012;16(2):284-92. [1087-1640]
15. Eggers C, Gruner U, Fink G, Nowak D. T-DCS-preconditioned low-frequency rTMS of the hand area of M1 to improve bradykinesia in Parkinson's disease. Journal of Neurology 2009;256:S142. [0340-5354]
16. Gruner U, Eggers C, Ameli M, Sarfeld AS, Fink GR, Nowak DA. 1 Hz rTMS preconditioned by tDCS over the primary motor cortex in Parkinson's disease: effects on bradykinesia of arm and hand. Journal of Neural Transmission 2010; Vol. 117, issue 2:207-16. [0300-9564]
17. Manenti R, Brambilla M, Rosini S, Orizio I, Ferrari C, Borroni B, et al. Time up and go task performance improves after transcranial direct current stimulation in patient affected by Parkinson's disease. Neuroscience Letters 2014;580:74-7. [0304-3940]
18. Pereira JB, Junque C, Bartres-Faz D, Marti MJ, Sala-Llonch R, Compta Y, et al. Modulation of verbal fluency networks by transcranial direct current stimulation (tDCS) in Parkinson's disease. Brain Stimulation 2013;6(1):16-24. [1935-861X]
19. Schollmann A, Weis D, Wasserka B, Kruger R, Plewnia C, Scholten M. Anodal tDCS to the left sensorimotor area induces a short-lasting increase of parieto-occipital alpha activity in Parkinson's disease. Clinical Neurophysiology 2015;8:e136-7.
20. von Papen M, Fisse M, Sarfeld A-S, Fink GR, Nowak DA. The effects of 1 Hz rTMS preconditioned by tDCS on gait kinematics in Parkinson's disease. Journal of Neural Transmission 2014;121(7):743-54. [1435-1463]
21. Mak M, Yu L. Effects of transcranial direct current stimulation on dual-task gait performance in patients with Parkinson's disease. Clinical Neurophysiology 2014;125(Suppl 1):S127.
22. Yu LL, Chan MY, Mak MKY. Effect of transcranial direct current stimulation (tDCS) on gait performance under concurrent cognitive task condition in patients with Parkinson's disease. Hong Kong Physiotherapy Journal 2011;29(2):97. [1013-7025]
23. Borgheresi A, Giovannelli F, Cozzi S, Antoniella L, Vanni P, Piccini C, et al. Effects of a short physical therapy program combined with transcranial direct current stimulation (tDCS) on freezing of gait in Parkinson's disease: Preliminary data from a randomized, sham-controlled study. Clinical Neurophysiology 2013;124(11):e200.
24. Capecci M, Andrenelli E, Orni C, Ceravolo MG. Bilateral prefrontal transcranial direct current stimulation (tDCS) in Parkinson's disease: A placebo controlled trial. Proceedings of the MDS 18th International Congress of Parkinson's Disease and Movement Disorders; 2014 June 8-12; Stockholm. Abstract Supplement. 2014; Vol. 29:S229-S230.
25. Falconer RA, Rogers SL, Torres-Yaghi Y, Turkeltaub P, Pagan F. Impact of tDCS in Parkinson's disease on mood, cognition, and motor deficits: A randomized, double-blinded, placebo-controlled trial. Proceedings of the MDS 19th International Congress of Parkinson's Disease and Movement Disorders; 2015 June 14-18; San Diego; California. Abstract Supplement. 2015; Vol. 30:S81.
26. Heldman DA, Pulliam CL, Blassucci LM, Giuffrida JP, Comella CL. Pilot study to evaluate transcranial direct current stimulation (tDCS) during sleep for the treatment of Parkinson's disease. Proceedings of the MDS 19th International Congress of Parkinson's Disease and Movement Disorders; 2015 June 14-18; San Diego; California. Abstract Supplement. 2015; Vol. 30:S425-S426.
27. NCT02125383 . ParkinStim: Transcranial direct current stimulation for Parkinson's disease. www.ClinicalTrials.gov/show/NCT02125383 (accessed 22 February 2016).
28. Yotnuengnit P, Piravej K. Effects of transcranial direct current stimulation (TDCS) plus physical therapy on gait in Parkinson. Archives of Physical Medicine and Rehabilitation 2013;94(10):e12.
29. NCT01113086 . Use of noninvasive brain stimulation in Parkinson's disease. www.ClinicalTrials.gov/show/NCT01113086 (accessed 25 February 2014).
30. NCT01602276 . The effect of tDCS on subcortical brain functioning. www.clinicaltrials.gov/show/NCT01602276 (accessed 22 February 2016).
31. NCT02205216 . Can tDCS enhance efficacy of rehabilitative intervention for freezing of gait in Parkinson's disease?. www.clinicaltrials.gov/show/NCT02205216 (accessed 22 February 2016).
32. NCT02250690 . Neuromodulation on motor function in Parkinson's disease. www.clinicaltrials.gov/show/NCT02250690 (accessed 22 February 2016).
33. NCT02266004 . Transcranial direct current stimulation for freezing of gait. www.clinicaltrials.gov/show/NCT02266004 (accessed 23 February 2016).
34. NCT02287207 . Effects of transcranial direct current stimulation on fine motor skills in Parkinson's disease: a pilot study. wwwclinicaltrials.gov/show/NCT02287207 (accessed 23 February 2016).
35. NCT02503930 . The effect of tDCS on a motor-cognitive dual-task performance of Parkinson's patients. www.clinicaltrials.gov/show/NCT02503930 (accessed 23 February 2016).
36. NCT02656316 . The effects of multi-focal tDCS on motor-cognitive dysfunctions in Parkinson's disease. www.clinicaltrials.gov/show/NCT02656316 (accessed 23 February 2016).
37. Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Archives of Neurology 1999;56(5):595-601. [0003-9942: (Print)]
38. Baker M, Gershanik OS. Parkinson's disease (3.8). Neurological Disorders. Public Health Challenges. Geneva, Switzerland: World Health Organization, 2006:140-50. [92-4-156336-2]
39. Benninger D. RE: Cochrane review about tDCS in Parkinson's disease: Request for further information [personal communication]. Email to: B Elsner 9 October 2014.
40. Bindman LJ, Lippold OCJ, Redfearn JW. The action of brief polarizing currents on the cerebral cortex of the rat (1) during current flow and (2) in the production of long-lasting after-effects. Journal of Physiology 1964;172(3):369-82.
41. Caslake R, Taylor K, Scott N, Gordon J, Harris C, Wilde K, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism & Related Disorders 2013;19(5):515-21. [1353-8020]
42. Chen R. Transcranial direct current stimulation as a treatment for Parkinson's disease - interesting, but not ready for prime time. Journal of Neurology, Neurosurgery and Psychiatry 2010;81(10):1061. [1468-330X]
43. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd Edition. Mahwah, New Jersey: Lawrence Earlbaum Associates, 1988.
44. Crosby NJ, Deane K, Clarke CE. Amantadine in Parkinson's disease. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003468]
45. Deane K, Jones DE, Ellis-Hill C, Clarke CE, Playford ED, Ben-Shlomo Y. Physiotherapy for Parkinson's disease: a comparison of techniques. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002815]
46. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
47. Elahi B, Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function - systematic review of controlled clinical trials. Movement Disorders 2009;24(3):357-63. [1531-8257: (Electronic)]
48. Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving aphasia in patients after stroke. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD009760.pub2]
49. Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving function and activities of daily living in patients after stroke. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD009645.pub2]
50. Martinez-Martin P, Rodriguez-Blazquez C, João Forjaz M, Chaudhuri KR. Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Goldstein M, Calne D editor(s). Recent Developments in Parkinson's Disease. Vol. 2, Florham Park, NJ: Macmillan Healthcare Information, 1987:153-63.
51. Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurology 2012;11(5):429-42. [1474-4465: (Electronic)]
52. Gandiga PC, Hummel FC, Cohen LG. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clinical Neurophysiology 2006;117:845-50.
53. McMaster University (developed by Evidence Prime, Inc.). GRADEproGDT: GRADEpro Guideline Development Tool [www.guidelinedevelopment.org]. Hamilton: McMaster University (developed by Evidence Prime, Inc.), 2015.
54. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, et al. Rating quality of evidence and strength of recommendations: What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995-8.
55. Hesse S, Waldner A, Mehrholz J, Tomelleri C, Pohl M, Werner C. Combined transcranial direct current stimulation and robot-assisted arm training in subacute stroke patients: an exploratory, randomized multicenter trial. Neurorehabilitation and Neural Repair 2011;25(9):838-46.
56. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
57. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality.. Neurology 1967;17(5):427-42.
58. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry 1992;55(3):181-4. [PUBMED: 1564476]
59. Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G. Burden of illness in Parkinson's disease. Movement Disorders 2005;20(11):1449-54. [0885-3185: (Print)]
60. Jankovic J. Complications and limitations of drug therapy for Parkinson's disease. Neurology 2000;55(12 Suppl 6):S2-6. [PUBMED: 11188970]
61. Jeffery DT, Norton JA, Roy FD, Gorassini MA. Effects of transcranial direct current stimulation on the excitability of the leg motor cortex. Experimental Brain Research 2007;182(2):281-7.
62. Johnell O, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age and Ageing 1992;21(1):32-8. [PUBMED: 1553857]
63. Kaski D, Quadir S, Patel M, Yousif N, Bronstein AM. Enhanced locomotor adaptation aftereffect in the "broken escalator" phenomenon using anodal tDCS. Journal of Neurophysiology 2012;107(9):2493-505. [0022-3077]
64. Kaski D. RE: Cochrane review about tDCS in Parkinson's disease: Request for further information [personal communication]. Email to: B Elsner 18 August 2014.
65. Koch G. Do studies on cortical plasticity provide a rationale for using non-invasive brain stimulation as a treatment for Parkinson's disease patients?. Frontiers in Neurology 2013;4:180. [1664-2295: (Electronic)]
66. Lang N, Siebner HR, Ward NS, Lee L, Nitsche MA, Paulus W, et al. How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain?. European Journal of Neuroscience 2005;22(2):495-504.
67. Lindenberg R, Nair D, Zhu LL, Renga V, Schlaug G. Non-invasive motor cortex stimulation after stroke: the effect of number of sessions on outcome. Stroke 2011;42(3):e72.
68. Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. Journal of Neurology, Neurosurgery and Psychiatry 2002;72(2):241-8. [0022-3050: (Print)]
69. Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M. Treadmill training for patients with Parkinson's disease. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007830.pub2]
70. Monte-Silva K. Re: Your trial NCT01877148 meets inclusion criteria of our Cochrane review about tDCS in Parkinson's disease - Request of further information [personal communication]. Email to: B Elsner 25 August 2014.
71. Motto Cristina CM, Tamma F, Candelise L. Deep brain stimulation of subthalamic nucleus for Parkinson's disease. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD004491]
72. Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 2001;57:1899-901.
73. Nitsche MA, Nitsche MS, Klein CC, Tergau F, Rothwell JC, Paulus W. Level of action of cathodal DC polarisation induced inhibition of the human motor cortex. Journal of Physiology 2003;114:600-4.
74. Nowak DA, Grefkes C, Ameli M, Fink GR. Interhemsipsheric competition after stroke: brain stimulation to enhance recovery of function of the affected hand. Neurorehabilitation and Neural Repair 2009;23(7):641-56.
75. Nutt JG. Levodopa-induced dyskinesia: review, observations, and speculations. Neurology 1990;40(2):340-5. [PUBMED: 2405297]
76. Purpura DP, McMurtry JG. Intracellular activities and evoked potential changes during polarization of motor cortex. Journal of Neurophysiology 1965;28(1):166-85.
77. Reis J, Schambra HM, Cohen LG, Buch ER, Fritsch B, Zarahn E, et al. Noninvasive cortical stimulation enhances motor skill acquisition over multiple days through an effect on consolidation. Proceedings of the National Academy of Sciences of the United States of America 2009;106(5):1590-5.
78. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
79. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease?. Journal of Neurology, Neurosurgery and Psychiatry 2000;69(3):308-12. [0022-3050: (Print)]
80. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2000;69(1):67-73. [0022-3050: (Print)]
81. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML editor(s). Third Symposium on Parkinson's disease. Edinburgh: Livingstone, 1969:152-7.
82. Shearer J, Green C, Counsell C, Zajicek J. The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease. Journal of Neurology 2012;259(3):462-8. [0340-5354]
83. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the Unified Parkinson's Disease Rating Scale. Archives of Neurology 2010;67(1):64-70. [0003-9942]
84. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
85. Stowe R, Ives N, Clarke CE, Van H, Ferreira J, Hawker RJ, et al. Dopamine agonist therapy in early Parkinson's disease. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006564.pub2]
86. Verheyden G. RE: Cochrane review on tDCS for improving movement disorders in Parkinson's disease [personal communication]. Email to: B Elsner 27 May 2014.
87. Wu AD, Fregni F, Simon DK, Deblieck C, Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics 2008;5(2):345-61. [1933-7213: (Print)]